David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$686M |
| 2 |
Walt Disney
DIS
|
+$555M |
| 3 |
Palantir
PLTR
|
+$522M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$493M |
| 5 |
TSMC
TSM
|
+$464M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$981M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$951M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$596M |
| 4 |
Eli Lilly
LLY
|
+$555M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 36.5% |
| 2 | Technology | 15.18% |
| 3 | Healthcare | 9.91% |
| 4 | Consumer Discretionary | 9.25% |
| 5 | Financials | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
iShares S&P 500 Growth ETF
IVW
$77.2B
| $1.54M | ﹤0.01% |
+16,575
| New | +$1.67M |
|
2677
Rentokil
RTO
$11.8B
| $1.54M | ﹤0.01% |
+67,089
| New | +$1.62M |
|
2678
Bioventus
BVS
$942M
| $1.53M | ﹤0.01% |
167,751
+7,095
| +4% | +$70.9K |
|
2679
Matthews International
MATW
$656M
| $1.53M | ﹤0.01% |
68,738
-35,556
| -34% | -$925K |
|
2680
PUT
Dynatrace
DT
$15.4B
| $1.53M | ﹤0.01% |
32,400
-10,400
| -24% | -$569K |
|
2681
Design Therapeutics
DSGN
$954M
| $1.53M | ﹤0.01% |
395,251
-117,079
| -23% | -$559K |
|
2682
PUT
Ryder
R
$9.51B
| $1.52M | ﹤0.01% |
10,600
-15,400
| -59% | -$2.4M |
|
2683
Franklin Covey
FC
$230M
| $1.52M | ﹤0.01% |
55,166
+15,340
| +39% | +$508K |
|
2684
908 Devices
MASS
$459M
| $1.52M | ﹤0.01% |
339,715
+253,855
| +296% | +$752K |
|
2685
Qiagen
QGEN
$9.03B
| $1.52M | ﹤0.01% |
37,861
-203,377
| -84% | -$8.56M |
|
|
LOGC
2686
DELISTED
ContextLogic
LOGC
| $1.51M | ﹤0.01% |
216,931
+17,111
| +9% | +$127K |
|
|
CHAR
2687
Charlton Aria Acquisition Corp
CHAR
$120M
| $1.51M | ﹤0.01% |
150,000
| – | – |
|
2688
CALL
Emerson Electric
EMR
$88B
| $1.51M | ﹤0.01% |
+13,800
| New | +$1.66M |
|
2689
CALL
ServiceNow
NOW
$143B
| $1.51M | ﹤0.01% |
9,500
-60,500
| -86% | -$11.7M |
|
2690
PUT
Teva Pharmaceuticals
TEVA
$43.8B
| $1.51M | ﹤0.01% |
98,300
-41,200
| -30% | -$736K |
|
2691
PUT
Jefferies Financial Group
JEF
$12.2B
| $1.51M | ﹤0.01% |
28,200
-10,700
| -28% | -$726K |
|
2692
Stantec
STN
$8.4B
| $1.51M | ﹤0.01% |
18,200
+7,400
| +69% | +$592K |
|
|
EMBJ
2693
Embraer S.A. ADS
EMBJ
$13.4B
| $1.5M | ﹤0.01% |
+32,567
| New | +$1.45M |
|
2694
Cousins Properties
CUZ
$4.85B
| $1.5M | ﹤0.01% |
51,003
+1,831
| +4% | +$54.8K |
|
|
GSHRU
2695
Gesher Acquisition Corp II Units
GSHRU
| $1.5M | ﹤0.01% |
+150,000
| New | +$1.5M |
|
2696
CALL
Hilton Worldwide
HLT
$73.3B
| $1.5M | ﹤0.01% |
6,600
-20,500
| -76% | -$5.11M |
|
2697
MillerKnoll
MLKN
$1.6B
| $1.5M | ﹤0.01% |
+78,351
| New | +$1.67M |
|
|
GOOD
2698
Gladstone Commercial Corp
GOOD
$628M
| $1.5M | ﹤0.01% |
+99,870
| New | +$1.57M |
|
2699
CALL
Plug Power
PLUG
$3.17B
| $1.5M | ﹤0.01% |
1,108,000
-521,100
| -32% | -$991K |
|
2700
PUT
Steven Madden
SHOO
$3.27B
| $1.49M | ﹤0.01% |
+56,100
| New | +$1.97M |
|
Similar funds
David Shaw's Q1 2025 Portfolio in Review
As of Q1 2025, David Shaw held 4,902 positions worth $112B, down 18% from $136B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $6.08B in Q1 2025, closing 704 positions and reducing 1,734 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $951M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 36% of assets, down from 45% a quarter earlier, followed by Technology and Healthcare.
Against the trend, David Shaw opened a new position in KKR & Co 6.25% Series D Preferred Stock worth $88.2M.
- David Shaw's largest Q1 2025 buy was KKR & Co 6.25% Series D Preferred Stock: 1,800,000 shares worth $88.2M.
- David Shaw added most to GE Vernova in Q1 2025, an estimated $686M increase.
- David Shaw's biggest Q1 2025 reduction was Boeing, cutting an estimated $981M.
- David Shaw fully exited iShares Core S&P 500 ETF in Q1 2025, selling an estimated $951M.
- David Shaw's ten largest holdings make up 11% of its $112B portfolio in Q1 2025.
- David Shaw opened 569 new positions and closed 704 in Q1 2025.
- David Shaw's portfolio value fell 18% quarter-over-quarter to $112B.
Based on D.E. Shaw & Co's 13F filing for Q1 2025, filed 15 May 2025.